JP2521170B2 - 精神安定活性を有するピリミジニルピペラジニルアルキルアゾ―ル誘導体 - Google Patents

精神安定活性を有するピリミジニルピペラジニルアルキルアゾ―ル誘導体

Info

Publication number
JP2521170B2
JP2521170B2 JP2031353A JP3135390A JP2521170B2 JP 2521170 B2 JP2521170 B2 JP 2521170B2 JP 2031353 A JP2031353 A JP 2031353A JP 3135390 A JP3135390 A JP 3135390A JP 2521170 B2 JP2521170 B2 JP 2521170B2
Authority
JP
Japan
Prior art keywords
piperazinyl
butyl
pyrimidinyl
pyrazole
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2031353A
Other languages
English (en)
Japanese (ja)
Other versions
JPH032179A (ja
Inventor
コロンボ ピノル アウグスト
フリゴラ コンスタンサ ジョルジュ
パレス コロミナス フアン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RABO DERU DOKUTORU ESUTEBE SA
Original Assignee
RABO DERU DOKUTORU ESUTEBE SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RABO DERU DOKUTORU ESUTEBE SA filed Critical RABO DERU DOKUTORU ESUTEBE SA
Publication of JPH032179A publication Critical patent/JPH032179A/ja
Application granted granted Critical
Publication of JP2521170B2 publication Critical patent/JP2521170B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2031353A 1989-02-09 1990-02-08 精神安定活性を有するピリミジニルピペラジニルアルキルアゾ―ル誘導体 Expired - Lifetime JP2521170B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8901700A FR2642759B1 (fr) 1989-02-09 1989-02-09 Derives de pyrimidyl-piperazinyl-alkyl azoles avec activite anxiolytique et/ou tranquillisante
FR8901700 1989-02-09

Publications (2)

Publication Number Publication Date
JPH032179A JPH032179A (ja) 1991-01-08
JP2521170B2 true JP2521170B2 (ja) 1996-07-31

Family

ID=9378642

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2031353A Expired - Lifetime JP2521170B2 (ja) 1989-02-09 1990-02-08 精神安定活性を有するピリミジニルピペラジニルアルキルアゾ―ル誘導体

Country Status (18)

Country Link
US (1) US5128343A (sh)
EP (1) EP0382637B1 (sh)
JP (1) JP2521170B2 (sh)
KR (1) KR950000779B1 (sh)
AT (1) ATE92059T1 (sh)
AU (1) AU623734B2 (sh)
CA (1) CA2009480A1 (sh)
DD (1) DD292000A5 (sh)
DE (1) DE69002341T2 (sh)
DK (1) DK0382637T3 (sh)
ES (1) ES2021941A6 (sh)
FR (1) FR2642759B1 (sh)
HU (1) HU204817B (sh)
NO (1) NO176880C (sh)
PT (1) PT93095B (sh)
RU (1) RU2071474C1 (sh)
YU (1) YU48071B (sh)
ZA (1) ZA90929B (sh)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219855A (en) * 1988-01-29 1993-06-15 Mitsubishi Kasei Corporation Anxiolytic drug
FR2654621B1 (fr) * 1989-11-22 1994-09-23 Esteve Labor Dr Inhibition du syndrome d'abstinence.
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
US5646281A (en) * 1990-12-28 1997-07-08 Neurogen Corporation Certain 4-piperidino- and piperazinomethyl-2-phenyl imidazole derivatives; dopamine receptor subtype specific ligands
US5681956A (en) * 1990-12-28 1997-10-28 Neurogen Corporation 4-aryl substituted piperazinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands
FR2671972B1 (fr) * 1991-01-25 1995-03-03 Esteve Labor Dr Utilisation de derives 1-h-azole-(omega-(4-(2-pyrimidinyl)-1-piperazinyl)-alkyl) pour la preparation de medicaments destines au traitement des troubles des fonctions cognitives.
FR2673628B1 (fr) * 1991-03-07 1993-07-09 Esteve Labor Dr Procede de preparation de derives d'aryl (ou heteroaryl)-piperazinyl-butyl-azoles.
FR2701260B1 (fr) * 1993-02-05 1995-05-05 Esteve Labor Dr Dérivés de 2-[4-(4-azolylbutyl)-1-pipérazinyl]-5-hydroxypyrimidine, leur préparation et leur application en tant que médicaments.
FR2705098B1 (fr) * 1993-05-10 1995-08-04 Esteve Labor Dr Procédé de préparation de 2-{4-[4-(chloro-1-pyrazolyl)butyl]1-pipérazinyl}pyrimidine (Lesopitron) .
ES2099031B1 (es) * 1995-05-31 1997-12-01 Esteve Labor Dr Nuevos polimorfos de diclorhidrato de lesopitron y sus formas hidratadas, procedimientos de preparacion y composiciones que los contienen.
FR2763950B1 (fr) * 1997-06-02 2002-09-20 Esteve Labor Dr 2- {4- [4-(4,5-dichloro-2-methylimidazol-1-yl)butyl] -1- piperazinyl }-5-fluoropyrimidine, sa preparation et son utilisation therapeutique
ES2125206B1 (es) * 1997-07-21 1999-11-16 Esteve Labor Dr Derivados de acil-piperazinil-pirimidinas, su preparacion y su aplicacion como medicamentos.
US6166205A (en) * 1998-09-02 2000-12-26 Neurogen Corporation 2-Aryl-4-(1-[4-heteroaryl]piperazin-1-yl)methylimidazoles: dopamine . D.sub4 receptor subtype ligands
US7332494B2 (en) 2000-08-14 2008-02-19 Janssen Pharmaceutica, N.V. Method for treating allergies using substituted pyrazoles
WO2002014315A2 (en) 2000-08-14 2002-02-21 Ortho Mcneil Pharmaceutical, Inc. Substituted pyrazoles
AU8125501A (en) 2000-08-14 2002-02-25 Ortho Mcneil Pharm Inc Substituted pyrazoles
ATE324372T1 (de) 2000-08-14 2006-05-15 Ortho Mcneil Pharm Inc Substituierte pyrazole
AU2001288714A1 (en) 2000-09-06 2002-03-22 Ortho-Mcneil Pharmaceutical, Inc. A method for treating allergies
ES2167276B1 (es) * 2000-10-20 2003-04-01 Esteve Labor Dr Nuevos derivados de cianoaril (o cianoheteroaril)-carbonil-piperazinil-pirimidinas, su preparacion y su aplicacion como medicamentos.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
US4367335A (en) * 1981-08-03 1983-01-04 Mead Johnson & Company Thiazolidinylalkylene piperazine derivatives
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4547499A (en) * 1984-05-10 1985-10-15 The Upjohn Company 2,4-Dihydro-2(omega-aminoalkyl)-1H-[1,2,4]triazolo[3,4-c]benzoxazin-1-one anti-allergy drug compounds, compositions and use
US4675403A (en) * 1985-10-16 1987-06-23 American Home Products Corporation 3-Aminoalkyl derivatives of 5,5-disubstituted hydantoins with psychotropic activity

Also Published As

Publication number Publication date
EP0382637A1 (fr) 1990-08-16
JPH032179A (ja) 1991-01-08
ATE92059T1 (de) 1993-08-15
DE69002341T2 (de) 1993-12-02
NO900411L (no) 1990-08-10
ZA90929B (en) 1990-11-28
EP0382637B1 (en) 1993-07-28
YU48071B (sh) 1997-01-08
PT93095B (pt) 1995-12-29
KR950000779B1 (ko) 1995-02-02
YU25790A (en) 1991-08-31
NO176880C (no) 1995-06-14
ES2021941A6 (es) 1991-11-16
NO900411D0 (no) 1990-01-29
FR2642759A1 (fr) 1990-08-10
AU4919290A (en) 1990-08-16
AU623734B2 (en) 1992-05-21
CA2009480A1 (fr) 1990-08-09
HUT53100A (en) 1990-09-28
DK0382637T3 (da) 1993-09-20
PT93095A (pt) 1990-08-31
DE69002341D1 (de) 1993-09-02
HU900716D0 (en) 1990-04-28
FR2642759B1 (fr) 1991-05-17
DD292000A5 (de) 1991-07-18
US5128343A (en) 1992-07-07
RU2071474C1 (ru) 1997-01-10
KR900012929A (ko) 1990-09-03
HU204817B (en) 1992-02-28
NO176880B (no) 1995-03-06

Similar Documents

Publication Publication Date Title
JP2521170B2 (ja) 精神安定活性を有するピリミジニルピペラジニルアルキルアゾ―ル誘導体
RU2180659C2 (ru) 4-(ариламинометилен)-2,4-дигидропиразол-3-оны, способ их получения и фармацевтическая композиция
DE60121590T2 (de) Pyrazolderivate
RU2170230C2 (ru) Новые производные пиразола, способ их получения и содержащие их фармацевтические композиции
EP0721455B1 (fr) Tetrahydropyridine-(ou 4-hydroxypiperidine) alkylazoles ayant une activite pour les recepteurs sigma et/ou 5ht1a
DE69106715T2 (de) Indolderivate als antiallergische und antiinflammatorische mittel.
JPH07121865B2 (ja) ｛ω−［４−（２−ピリミジニル）−１−ピペラジニルアルキル｝−１Ｈ−アゾール誘導体を含む認識機能の障害の治療剤
CA2199845C (en) Quinoxalinedione nmda receptor antagonists
JPH11217383A (ja) 化合物
FR2672052A1 (fr) Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
CN101128435A (zh) 作为代谢型谷氨酸受体激动剂用于治疗神经病学及精神病学病症的吡唑酮化合物
WO2008125014A1 (fr) Composés d'urée, leurs procédés de préparation et leurs utilisations pharmaceutiques
JPH0224821B2 (sh)
JP2001518906A (ja) セロトニン様作用薬としてのインダゾールアミド化合物
JPH04234387A (ja) ベンゾイミダゾールの新規誘導体、それらの製法、及びそれらの医薬用途
JP2009520013A (ja) ブラジキニンアンタゴニストとしての新規フェナンスリジン誘導体
JPH0699309B2 (ja) 離脱症候群関連障害治療用医薬製品
EP0610140B1 (fr) Dérivés de 2-[4-(4-azolylbutyl)-1-pipérazinyl]-5-hydroxypyrimidine, leur préparation et leur application en tant que médicaments
KR20150046456A (ko) 신규한 항진균성 옥소다이하이드로피리딘카보하이드라자이드 유도체
JPS62149617A (ja) 過酸化脂質生成抑制剤
JPH03246282A (ja) トリアゾリルヒドラジド誘導体、その製造方法、およびその誘導体を活性成分とする抗狭心症または胃潰瘍防止用製剤組成物とその製造方法
TW200418827A (en) 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them
JPH05508620A (ja) ４―（ヘテロ）アリールメチルオキシフェニルジアゾール誘導体、その製造法およびその治療への用途
KR840002242B1 (ko) 신규 이미다졸 화합물의 제조방법
JP2002507983A (ja) （１ｈ−イミダゾール−４−イル）ピペリジン誘導体、それらの製造およびそれらの治療における応用